Wood-smoke exposure as a response and survival predictor in erlotinib-treated nonsmall cell lung cancer patients.

[1]  H. Asamura,et al.  Clinicopathological Characteristics of Screen-Detected Lung Cancers , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[2]  O. Arrieta,et al.  Wood-Smoke Exposure as a Response and Survival Predictor in Erlotinib-treated Non-small Cell Lung Cancer Patients: An Open Label Phase II Study , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[3]  M. Reck,et al.  The global TRUST study of erlotinib in advanced non-small-cell lung cancer (NSCLC) , 2008 .

[4]  Renato Martins,et al.  Erlotinib in previously treated non-small-cell lung cancer. , 2005, The New England journal of medicine.

[5]  N. Reguart,et al.  Wood-smoke exposure (WSE) as a predictor of response and survival in erlotinib-treated non-small cell lung cancer (NSCLC) patients. , 2009, Journal of Thoracic Oncology.